
Jean-Baptiste Guillerme
BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art... | Paris, Paris, France
*50 free lookup(s) per month.
No credit card required.
Jean-Baptiste Guillerme’s Emails je****@in****.fr
Jean-Baptiste Guillerme’s Phone Numbers No phone number available.
Social Media
Jean-Baptiste Guillerme’s Location Paris, Paris, France
Jean-Baptiste Guillerme’s Expertise BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, California. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., was also the co-founder of PharMingen.
Jean-Baptiste Guillerme’s Current Industry Biolegend
Jean-Baptiste
Guillerme’s Prior Industry
Inserm
|
University Of Nantes Inserm U892 Cnrs 6299
|
Inserm U1016 Infection Immunity And Inflammation
|
Universite De Nantes
|
Biolegend
Not the Jean-Baptiste Guillerme you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Biolegend
Technical Application Scientist
Wed Nov 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Universite De Nantes
Postdoctoral Research Fellow
Sat Oct 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Inserm U1016 Infection Immunity And Inflammation
Post-doctoral research fellow
Fri Nov 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Oct 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Inserm
PhD in Immunology
Fri Oct 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Nantes Inserm U892 Cnrs 6299
Oncolytic Measles Virus and Anti-Tumor Virotherapy
Fri Oct 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)